AT becomes dysfunctional in obesity and generates a pro-inflammatory, hyperlipidemic, and insulin-resistant environment, which ultimately leads to the development of metabolic complications (e.g., diabetes) and cardiovascular complications (e.g., atherosclerosis) (4). This evidence concerns the gene INS and obesity disorder.